DATA TIMESTAMP
SENDER IDENTIFIER
SUBJECT & CONTENT PREVIEW
TS:
2014-06-20 19:28:42
ID:
josh@beaubiden.com
SUBJ:
Fwd: Join Chuck Todd for a special series on Delaware next week?
Hey guys, see below for a request from Chuckie Todd. My inclination is to decline. We probably shouldn't have Beau's first interview post-announcement with a national person like CTodd. Better to do something local first. Or else go big with a Robin Roberts or Savannah Gutherie or something. Thought
VIEW
TS:
2014-06-20 19:32:36
ID:
tedkaufman@comcast.net
SUBJ:
Re: Join Chuck Todd for a special series on Delaware next week?
I think he should not do it and there is no reason for him to call Todd. It is appropriate for Tim Mullaney to " decline by stating that Beau’s not doing interviews on politics at this time but we’ll look forward to keeping in touch for the future."
----- Original Message -----
From: "Josh Alcorn"
VIEW
TS:
2014-06-20 19:34:33
ID:
hking@bsfllp.com
SUBJ:
Privileged and Confidential
Vadim, Alan, Devon and Hunter - I apologize but an unexpected work emergency arose yesterday and it will take me to Court unexpectedly on Monday morning. It has also caused delay in me finishing the Memo on our overall case strategy that I had said I would send you by tonight. As a result, I would l
VIEW
TS:
2014-06-20 20:13:10
ID:
perowan@gmail.com
SUBJ:
Fwd: oscar.ardemagni@gmail.com has sent you a file via WeTransfer
---------- Forwarded message ----------
From: WeTransfer <noreply@wetransfer.com>
Date: Fri, Jun 20, 2014 at 10:26 AM
Subject: oscar.ardemagni@gmail.com has sent you a file via WeTransfer
To: "perowan@gmail.com" <perowan@gmail.com>
oscar.ardemagni@gmail.com
sent you some files ‘Dear Mr. Paul Rowan
VIEW
TS:
2014-06-20 20:16:02
ID:
vicki@emkinstitute.org
SUBJ:
Thank You for Attending the Edward M. Kennedy Institute Reception
--------------------------------------
To unsubscribe from this mailing list, please click here
https://www.eiseverywhere.com/emarketing/profile.php?id=TimDkumoyW3DxWaBFUep39HjSsSyPsFJWIk5UUjuVHI%3
VIEW
TS:
2014-06-20 20:22:05
ID:
timothy.j.cooney@jpmorgan.com
SUBJ:
Hey Hunter- Good seeing you and Beau a few weeks ago
Hunter: Good seeing you and Beau a few weeks ago. How does your schedule look in July for getting together for coffee-perhaps at the office or happy to host you here. Tim
Tim Cooney
Banker
J.P. Morgan
800 Connecticut Ave., NW 9th Floor
Washington D.C. 20006
(202) 533-2425 (o)
JPMorgan Chase Bank, N
VIEW
TS:
2014-06-20 20:26:03
ID:
kdodge@rosemontseneca.com
SUBJ:
Monday & Tuesday schedule of Calls ** Time is Eastern Time **
*Monday, June 23:*
10:00 AM – No Burisma call (Canceled)
2:00 PM – RSTP Update call - 202-446-0487, 333188#
3:30 PM - Call with Thea Haigh of Sunshine Sachs RE: Social Media training
- 202-446-0487 PIN 333188#
*Tuesday, June 24*:
10:00 AM – Burisma call - Dial-In: 1-719-867-4927 (Intl) or 1-
VIEW
TS:
2014-06-20 20:27:03
ID:
josh@beaubiden.com
SUBJ:
Re: Join Chuck Todd for a special series on Delaware next week?
Let the office decline, for sure. But I don't see the harm in Beau reaching out and at least thanking him for thinking of him. Chuck T is one of the few people at msnbc who isn't a complete jerk, and he does seem to like Beau. He does more hits on the Nightly News than anyone else from msnbc, so it
VIEW
TS:
2014-06-20 20:30:00
ID:
annualfunds@sidwell.edu
SUBJ:
Join your Sidwell Friends in the next 10 days
Friday - June 20, 2014
Only 10 days left to make your gift…only $30,000 needed to reach the Annual Fund goal!Please consider supporting Sidwell Friends and making a gift to the Annual Fund before the end of the fiscal year on June 30.Your participation demonstrates your commitment to the Sidwell F
VIEW
TS:
2014-06-20 20:59:34
ID:
perowan@gmail.com
SUBJ:
Fwd: FDA Accepts 23andMe's 510(k) Application; UK Dementia Funding; Courtagen Raises Funds; More
Sent from my iPhone
Begin forwarded message:
> From: GenomeWeb Daily News <newsletters@genomeweb.com>
> Date: June 20, 2014 at 3:55:24 PM EDT
> To: perowan@gmail.com
> Subject: FDA Accepts 23andMe's 510(k) Application; UK Dementia Funding; Courtagen Raises Funds; More
> Reply-To: newsletters@genom
VIEW